Achieve Life Sciences, Inc.
NASDAQ:ACHV
4.71 (USD) • At close November 1, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Achieve Life Sciences, Inc. |
Symbool | ACHV |
Munteenheid | USD |
Prijs | 4.71 |
Beurswaarde | 161,747,523 |
Dividendpercentage | 0% |
52-weken bereik | 3.03 - 5.98 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. John A. Bencich M.B.A. |
Website | https://www.achievelifesciences.com |
An error occurred while fetching data.
Over Achieve Life Sciences, Inc.
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)